Liu Y - Search Results

1

Design, synthesis, and evaluation of pirfenidone-NSAIDs conjugates for the treatment of idiopathic pulmonary fibrosis.

Lu X, Zhu C, Gao Y, Yu Z, Yan Q, Liu Y, Luo M, Shi X. Lu X, et al. Among authors: liu y. Bioorg Chem. 2024 Feb;143:107018. doi: 10.1016/j.bioorg.2023.107018. Epub 2023 Dec 6. Bioorg Chem. 2024. PMID: 38071874

2

Design, synthesis and antitumor activity evaluation of novel indole acrylamide derivatives as IMPDH inhibitors.

Jia HW, Yang HL, Xiong ZL, Deng MH, Wang T, Liu Y, Cheng M. Jia HW, et al. Among authors: liu y. Bioorg Chem. 2022 Dec;129:106213. doi: 10.1016/j.bioorg.2022.106213. Epub 2022 Oct 21. Bioorg Chem. 2022. PMID: 36308854

3

Design, synthesis, and evaluation of N-methyl-propargylamine derivates as isoform-selective monoamine oxidases inhibitors for the treatment of nervous system diseases.

Zhang K, Liu Y, Jia H, Wang H, Deng M, Liu Y, Zhao X, Xiu X, Li Z, Yang H, Cheng M. Zhang K, et al. Among authors: liu y. Bioorg Chem. 2023 May;134:106441. doi: 10.1016/j.bioorg.2023.106441. Epub 2023 Feb 23. Bioorg Chem. 2023. PMID: 36854233

4

Novel Ziyuglycoside II derivatives inhibit MCF-7 cell proliferation via inducing apoptosis and autophagy.

Zhong Y, Tian X, Jiang X, Dang W, Cheng M, Li N, Liu Y. Zhong Y, et al. Among authors: liu y. Bioorg Chem. 2023 Oct;139:106752. doi: 10.1016/j.bioorg.2023.106752. Epub 2023 Jul 24. Bioorg Chem. 2023. PMID: 37499529

5

Design, synthesis and evaluation of EZH2-based PROTACs targeting PRC2 complex in lymphoma.

Xie H, Xu W, Liang J, Liu Y, Zhuo C, Zou X, Luo W, Xiao J, Lin Y, Chen L, Li H. Xie H, et al. Among authors: liu y. Bioorg Chem. 2023 Nov;140:106762. doi: 10.1016/j.bioorg.2023.106762. Epub 2023 Aug 8. Bioorg Chem. 2023. PMID: 37572533

6

Design, synthesis and biological evaluation of novel 2,4-diaminopyrimidine cinnamyl derivatives as inhibitors of FAK with potent anti-gastric cancer activities.

Liu Y, Kong LJ, Li N, Liu YH, Jia MQ, Liu QG, Zhang SY, Song J. Liu Y, et al. Among authors: liu qg, liu yh. Bioorg Chem. 2023 Dec;141:106895. doi: 10.1016/j.bioorg.2023.106895. Epub 2023 Sep 30. Bioorg Chem. 2023. PMID: 37797456

7

Potential oral VEGFR2 inhibitors: Treatment of wet age-related macular degeneration.

Xiu X, Li M, Hu D, Jia H, Wang H, Liu Y, Zhao X, Li Z, Liu Y, Yang H, Cheng M. Xiu X, et al. Among authors: liu y. Bioorg Chem. 2024 Mar;144:107110. doi: 10.1016/j.bioorg.2024.107110. Epub 2024 Jan 10. Bioorg Chem. 2024. PMID: 38224636

8

Synthesis and preclinical evaluation of a novel PET/fluorescence dual-modality probe targeting fibroblast activation protein.

Zhang X, Huang J, Gong F, Cai Z, Liu Y, Tang G, Hu K. Zhang X, et al. Among authors: liu y. Bioorg Chem. 2024 May;146:107275. doi: 10.1016/j.bioorg.2024.107275. Epub 2024 Mar 13. Bioorg Chem. 2024. PMID: 38493637

9

Design and synthesis of hemicyanine-based NIRF probe for detecting Aβ aggregates in Alzheimer's disease.

Zhao X, Li Y, Li Z, Hu D, Zhang R, Li M, Liu Y, Xiu X, Jia H, Wang H, Liu Y, Yang H, Cheng M. Zhao X, et al. Among authors: liu y. Bioorg Chem. 2024 Sep;150:107514. doi: 10.1016/j.bioorg.2024.107514. Epub 2024 May 31. Bioorg Chem. 2024. PMID: 38870704

10

Discovery of novel CDK9 inhibitor with tridentate ligand: Design, synthesis and biological evaluation.

Zhong Y, Xu J, Ding S, Cao H, Zhang Y, Hu B, Han S, Yang H, Cheng M, Li J, Sun Y, Liu Y. Zhong Y, et al. Among authors: liu y. Bioorg Chem. 2024 Sep;150:107550. doi: 10.1016/j.bioorg.2024.107550. Epub 2024 Jun 10. Bioorg Chem. 2024. PMID: 38878756

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209,210 results

Search Page

Filters